BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24297870)

  • 1. RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling.
    Kapralova K; Lanikova L; Lorenzo F; Song J; Horvathova M; Divoky V; Prchal JT
    Blood; 2014 Jan; 123(3):391-4. PubMed ID: 24297870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
    Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
    J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2.
    Wang W; Schwemmers S; Hexner EO; Pahl HL
    Blood; 2010 Jul; 116(2):254-66. PubMed ID: 20339092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Benign erythrocytosis" and other familial and congenital polycythemias.
    Prchal JT; Sokol L
    Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia vera patients.
    Bogeska R; Pahl HL
    Stem Cells Transl Med; 2013 Feb; 2(2):112-7. PubMed ID: 23341442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPN patients harbor recurrent truncating mutations in transcription factor NF-E2.
    Jutzi JS; Bogeska R; Nikoloski G; Schmid CA; Seeger TS; Stegelmann F; Schwemmers S; Gründer A; Peeken JC; Gothwal M; Wehrle J; Aumann K; Hamdi K; Dierks C; Kamar Wang W; Döhner K; Jansen JH; Pahl HL
    J Exp Med; 2013 May; 210(5):1003-19. PubMed ID: 23589569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycythemia and oxygen sensing.
    Maran J; Prchal J
    Pathol Biol (Paris); 2004 Jun; 52(5):280-4. PubMed ID: 15217714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.
    Sarangi S; Lanikova L; Kapralova K; Acharya S; Swierczek S; Lipton JM; Wolfe L; Prchal JT
    Pediatr Blood Cancer; 2014 Nov; 61(11):2104-6. PubMed ID: 24729484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.
    Peeken JC; Jutzi JS; Wehrle J; Koellerer C; Staehle HF; Becker H; Schoenwandt E; Seeger TS; Schanne DH; Gothwal M; Ott CJ; Gründer A; Pahl HL
    Blood; 2018 May; 131(18):2065-2073. PubMed ID: 29519804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets.
    Glembotsky AC; Bluteau D; Espasandin YR; Goette NP; Marta RF; Marin Oyarzun CP; Korin L; Lev PR; Laguens RP; Molinas FC; Raslova H; Heller PG
    J Thromb Haemost; 2014 May; 12(5):761-72. PubMed ID: 24606315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2.
    Siegwart LC; Schwemmers S; Wehrle J; Koellerer C; Seeger T; Gründer A; Pahl HL
    Exp Hematol; 2020 Jul; 87():42-47.e1. PubMed ID: 32593672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis].
    Aumann K; Frey AV; May AM; Hauschke D; Kreutz C; Marx JP; Timmer J; Werner M; Pahl HL
    Pathologe; 2013 Nov; 34 Suppl 2():201-9. PubMed ID: 24196613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.
    Kaufmann KB; Gründer A; Hadlich T; Wehrle J; Gothwal M; Bogeska R; Seeger TS; Kayser S; Pham KB; Jutzi JS; Ganzenmüller L; Steinemann D; Schlegelberger B; Wagner JM; Jung M; Will B; Steidl U; Aumann K; Werner M; Günther T; Schüle R; Rambaldi A; Pahl HL
    J Exp Med; 2012 Jan; 209(1):35-50. PubMed ID: 22231305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
    Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
    Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
    Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT
    Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
    Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
    J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the molecular biology of congenital polycythemias and polycythemia vera.
    Gregg XT; Prchal JT
    Curr Hematol Rep; 2005 May; 4(3):238-42. PubMed ID: 15865879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2.
    Goerttler PS; Kreutz C; Donauer J; Faller D; Maiwald T; März E; Rumberger B; Sparna T; Schmitt-Gräff A; Wilpert J; Timmer J; Walz G; Pahl HL
    Br J Haematol; 2005 Apr; 129(1):138-50. PubMed ID: 15801966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes.
    Zang C; Luyten A; Chen J; Liu XS; Shivdasani RA
    Sci Rep; 2016 Jul; 6():30255. PubMed ID: 27457419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
    Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
    Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.